Stock listing
NASDAQ:BCAX Bicara Therapeutics Inc. Stock
Home listing (NASDAQ) of Bicara Therapeutics Inc.
Follow Bicara Therapeutics Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:BCAX
$7.93 USD -1.20 (-13.1%)
Close on Nov 2, 2026
- Day range
- $7.87 – $9.17 USDNov 2, 2026
- Volume
- 2.50M sharesNov 2, 2026
- Market cap
- $524.8M USDAt the close on Nov 2, 2026 · price × 66.17M shares outstanding
- 52-week range
- $7.87 – $30.99 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $17.62M USDMedian day 670,400 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:BCAX · Home | $7.93 USD | -1.20 (-13.1%) | 2,501,416 | $9.06 | $9.165 | $7.87 | $9.13 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:BCAX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $7.93 | -1.20 | -13.1% | $9.06 | $9.165 | $7.87 | 2,501,416 | |
| $9.13 | -0.60 | -6.2% | $9.38 | $9.38 | $8.36 | 4,195,100 | |
| $9.73 | -0.03 | -0.3% | $9.79 | $10.19 | $9.35 | 3,190,900 | |
| $9.76 | -7.72 | -44.2% | $17.37 | $17.57 | $8.90 | 15,425,000 | |
| $17.48 | +0.59 | +3.5% | $16.91 | $17.59 | $16.60 | 609,300 | |
| $16.89 | -0.18 | -1.1% | $16.98 | $17.67 | $16.44 | 1,051,900 | |
| $17.07 | -0.54 | -3.1% | $17.53 | $17.85 | $16.98 | 730,200 | |
| $17.61 | -0.30 | -1.7% | $17.92 | $18.07 | $17.15 | 816,900 | |
| $17.91 | -0.44 | -2.4% | $18.31 | $18.78 | $17.90 | 656,700 | |
| $18.35 | +0.88 | +5.0% | $17.79 | $18.65 | $17.31 | 493,400 | |
| $17.47 | +0.69 | +4.1% | $16.92 | $17.60 | $16.60 | 865,400 | |
| $16.78 | -0.84 | -4.8% | $17.60 | $17.78 | $16.69 | 820,000 | |
| $17.62 | +0.28 | +1.6% | $17.51 | $17.95 | $17.25 | 662,100 | |
| $17.34 | 0.00 | 0.0% | $17.23 | $17.68 | $17.11 | 1,428,600 | |
| $17.34 | +0.01 | +0.1% | $17.29 | $17.61 | $17.01 | 1,267,100 | |
| $17.33 | -0.17 | -1.0% | $17.46 | $17.99 | $17.11 | 659,100 | |
| $17.50 | +0.24 | +1.4% | $17.19 | $17.82 | $16.88 | 716,000 | |
| $17.26 | +0.84 | +5.1% | $16.32 | $17.33 | $15.85 | 1,253,600 | |
| $16.42 | -0.14 | -0.8% | $16.44 | $17.11 | $16.25 | 915,600 | |
| $16.56 | -0.73 | -4.2% | $17.43 | $17.52 | $16.31 | 981,200 | |
| $17.29 | -0.34 | -1.9% | $17.63 | $19.12 | $17.13 | 640,700 | |
| $17.63 | -0.57 | -3.1% | $18.50 | $18.96 | $17.56 | 763,100 | |
| $18.20 | -0.41 | -2.2% | $18.61 | $19.23 | $18.12 | 698,000 | |
| $18.61 | +0.05 | +0.3% | $18.71 | $18.95 | $18.39 | 905,400 | |
| $18.56 | -0.24 | -1.3% | $18.88 | $19.39 | $18.51 | 599,800 | |
| $18.80 | -0.41 | -2.1% | $19.21 | $19.26 | $18.59 | 775,300 | |
| $19.21 | -0.57 | -2.9% | $19.86 | $19.89 | $19.17 | 662,500 | |
| $19.78 | -0.705 | -3.4% | $20.43 | $20.84 | $19.33 | 1,374,200 | |
| $20.49 | -2.295 | -10.1% | $22.78 | $23.12 | $20.48 | 954,800 | |
| $22.78 | +0.77 | +3.5% | $22.31 | $22.91 | $22.23 | 622,200 | |
| $22.01 | -0.63 | -2.8% | $23.06 | $23.34 | $21.95 | 315,400 | |
| $22.64 | +0.05 | +0.2% | $22.66 | $22.86 | $22.26 | 934,200 | |
| $22.59 | +0.59 | +2.7% | $22.40 | $22.98 | $22.38 | 492,000 | |
| $22.00 | -0.67 | -3.0% | $22.74 | $23.25 | $21.86 | 798,300 | |
| $22.67 | -0.53 | -2.3% | $23.11 | $23.11 | $22.47 | 706,500 | |
| $23.20 | +0.39 | +1.7% | $22.88 | $23.62 | $22.51 | 426,300 | |
| $22.81 | -0.29 | -1.3% | $23.29 | $24.23 | $22.40 | 471,500 | |
| $23.10 | -0.54 | -2.3% | $23.31 | $23.63 | $22.50 | 644,800 | |
| $23.64 | -0.07 | -0.3% | $23.37 | $23.98 | $23.10 | 550,200 | |
| $23.71 | +0.54 | +2.3% | $22.64 | $23.98 | $22.26 | 710,000 | |
| $23.17 | -0.17 | -0.7% | $23.09 | $23.47 | $22.85 | 296,900 | |
| $23.34 | -0.22 | -0.9% | $23.72 | $24.21 | $22.85 | 259,700 | |
| $23.56 | +0.14 | +0.6% | $23.64 | $24.35 | $22.82 | 518,800 | |
| $23.42 | +0.30 | +1.3% | $22.86 | $23.47 | $22.63 | 429,900 | |
| $23.12 | -0.31 | -1.3% | $23.35 | $23.51 | $22.61 | 512,000 | |
| $23.43 | -1.40 | -5.6% | $24.45 | $24.59 | $23.36 | 524,700 | |
| $24.83 | +0.10 | +0.4% | $24.78 | $25.24 | $24.26 | 445,000 | |
| $24.73 | +0.15 | +0.6% | $24.53 | $24.87 | $24.03 | 423,800 | |
| $24.58 | +1.00 | +4.2% | $23.94 | $24.94 | $23.91 | 410,310 | |
| $23.58 | -0.32 | -1.3% | $23.63 | $24.24 | $22.94 | 669,731 | |
| $23.90 | -0.49 | -2.0% | $24.73 | $25.56 | $23.77 | 496,300 | |
| $24.39 | -1.47 | -5.7% | $25.44 | $25.79 | $24.27 | 449,000 | |
| $25.86 | +0.94 | +3.8% | $26.09 | $26.95 | $25.04 | 670,400 | |
| $24.92 | -0.02 | -0.1% | $24.71 | $25.45 | $24.47 | 446,100 | |
| $24.94 | +0.66 | +2.7% | $24.28 | $25.00 | $24.13 | 434,600 | |
| $24.28 | +0.65 | +2.8% | $23.51 | $24.97 | $23.27 | 479,900 | |
| $23.63 | -1.00 | -4.1% | $24.89 | $24.93 | $23.33 | 751,500 | |
| $24.63 | +0.87 | +3.7% | $24.00 | $25.14 | $23.88 | 810,300 | |
| $23.76 | -3.97 | -14.3% | $22.80 | $26.92 | $22.80 | 1,716,283 | |
| $27.73 | -0.33 | -1.2% | $27.83 | $28.40 | $27.07 | 949,332 | |
| $28.06 | +0.55 | +2.0% | $27.90 | $28.43 | $26.90 | 570,600 | |
| $27.51 | +1.62 | +6.3% | $26.11 | $27.68 | $26.06 | 704,000 | |
| $25.89 | -0.21 | -0.8% | $26.31 | $26.62 | $25.34 | 818,300 | |
| $26.10 | +0.36 | +1.4% | $26.24 | $26.87 | $25.80 | 815,100 | |
| $25.74 | -1.36 | -5.0% | $26.85 | $26.85 | $25.70 | 399,000 |
- Ticker
- NASDAQ:BCAX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 2, 2026
Bicara Therapeutics to Report Third Quarter 2026 Financial Results and Business Updates on November 9, 2026, at 8: 30 AM ET
Latest earnings call · Aug 11, 2026
Bicara Therapeutics (NASDAQ:BCAX) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Aug 11, 2026
Q2 2026 Earnings Presentation
Earnings · 8 slides
Calls
Upcoming
Bicara Therapeutics (NASDAQ:BCAX) Q3 2026 Earnings Call
Mon, Nov 09, 2026 · 8:30 AM ET
Register
Replays
Bicara Therapeutics (NASDAQ:BCAX) Q2 2026 Earnings Call
Tue, Aug 11, 2026 · 8:30 AM ET
Watch TranscriptBicara Therapeutics (NASDAQ:BCAX) Q1 2026 Earnings Call
Mon, May 11, 2026 · 8:30 AM ET
Watch TranscriptBicara Therapeutics (NASDAQ:BCAX) Q4 2025 Earnings Call
Mon, Mar 30, 2026 · 8:30 AM ET
Watch Transcript
Latest news
Bicara Therapeutics to Report Third Quarter 2026 Financial Results and Business Updates on November 9, 2026, at 8: 30 AM ET
Nov 2, 2026
Closed $7.93 (-13.1%) on Nov 2, 2026
Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Oct 5, 2026
Closed $17.29 (-1.9%) on Oct 5, 2026
Bicara Therapeutics Reports Second Quarter 2026 Progress and Announces Strategic Leadership Transitions Marking Next Era of Execution and Growth
Aug 11, 2026
Closed $23.76 (-14.3%) on Aug 11, 2026
Bicara Therapeutics to Report Second Quarter 2026 Financial Results and Business Updates on August 11, 2026, at 8: 30 AM ET
Aug 4, 2026
Closed $26.10 (+1.4%) on Aug 4, 2026
Bicara Therapeutics Announces Appointments of Jeremy Bender and Christy Oliger to Board of Directors
Jul 28, 2026
Closed $26.88 (-3.3%) on Jul 28, 2026
Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
May 13, 2026
Closed $20.99 (-6.2%) on May 13, 2026
Bicara Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
May 11, 2026
Closed $22.92 (+1.5%) on May 11, 2026
Bicara Therapeutics to Report First Quarter 2026 Financial Results and Business Updates on May 11, 2026, at 8: 30 AM ET
May 4, 2026
Closed $22.72 (+4.8%) on May 4, 2026
Bicara Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Mar 30, 2026
Closed $19.04 (+3.6%) on Mar 30, 2026
Bicara Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Business Updates on March 30, 2026, at 8: 30 AM ET
Mar 23, 2026
Closed $18.39 (-0.1%) on Mar 23, 2026
Decks
Q2 2026 Earnings Presentation
Earnings · 8 slides · Aug 11, 2026
Investor Presentation (August 2026)
Investor deck · 37 slides · August 2026
Q1 2026 Earnings Presentation
Earnings · 12 slides · May 11, 2026
Q4 2025 Earnings Presentation
Earnings · 36 slides · Mar 30, 2026
Bicara Therapeutics Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 22 in the last 12 months · 35 in all · newest Nov 2, 2026 · oldest 2025
- Calls
- 3 calls with a replay · 3 with a transcript · latest Aug 11, 2026
- Decks
- 9 decks · latest Aug 11, 2026
Where Bicara Therapeutics Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:BCAX · Home listing · This page | NASDAQ | United States | USD |
| BOATS:BCAX | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Bicara Therapeutics Inc.